- Home
- RVP vs BOLD Comparison
RVP vs BOLD Comparison
Compare RVP & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVP
- BOLD
- Stock Information
- Founded
- RVP 1994
- BOLD 2018
- Country
- RVP United States
- BOLD United States
- Employees
- RVP N/A
- BOLD N/A
- Industry
- RVP Medical/Dental Instruments
- BOLD
- Sector
- RVP Health Care
- BOLD
- Exchange
- RVP Nasdaq
- BOLD Nasdaq
- Market Cap
- RVP 25.1M
- BOLD 24.4M
- IPO Year
- RVP 2001
- BOLD 2024
- Fundamental
- Price
- RVP $0.82
- BOLD $1.15
- Analyst Decision
- RVP
- BOLD Buy
- Analyst Count
- RVP 0
- BOLD 4
- Target Price
- RVP N/A
- BOLD $4.00
- AVG Volume (30 Days)
- RVP 77.0K
- BOLD 77.7K
- Earning Date
- RVP 11-13-2025
- BOLD 11-06-2025
- Dividend Yield
- RVP N/A
- BOLD N/A
- EPS Growth
- RVP N/A
- BOLD N/A
- EPS
- RVP N/A
- BOLD N/A
- Revenue
- RVP $38,161,712.00
- BOLD N/A
- Revenue This Year
- RVP N/A
- BOLD N/A
- Revenue Next Year
- RVP N/A
- BOLD N/A
- P/E Ratio
- RVP N/A
- BOLD N/A
- Revenue Growth
- RVP N/A
- BOLD N/A
- 52 Week Low
- RVP $0.56
- BOLD $1.00
- 52 Week High
- RVP $0.94
- BOLD $4.72
- Technical
- Relative Strength Index (RSI)
- RVP 57.25
- BOLD 49.88
- Support Level
- RVP $0.79
- BOLD $1.13
- Resistance Level
- RVP $0.83
- BOLD $1.16
- Average True Range (ATR)
- RVP 0.03
- BOLD 0.04
- MACD
- RVP -0.00
- BOLD 0.00
- Stochastic Oscillator
- RVP 55.44
- BOLD 55.56
About RVP Retractable Technologies Inc.
Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.